Search PubMed⌕ Search

Biomedical subjects

A Abrahamov

Publications and source records attributed to A Abrahamov.

At least 109 records · Page 6Linked to original sources

Viral infections and phenotypic heterogeneity in Gaucher disease.

Gaucher disease, the most common lysosomal storage disorder, is remarkable for its tremendous phenotypic heterogeneity even among patients with the same genotype. Beyond mutations at the 1q21 locus, there may be other genetic and environmental factors that impact on the natural course of Gaucher disease and indeed may trigger symptoms and signs. Among candidate events are viral infections such as the Epstein-Barr virus (EBV) or cytomegalovirus (CMV). The purpose of this study was to ascertain if indeed prior infection with EBV or CMV in patients homozygous for the most common mutation, N370S (1226G), is predictive of a more severe phenotype. Evidence for an EBV virus was IgG and IgM antibodies to early antigen and IgG anti-EBNA. For CMV infection, IgG and IgM antibodies were sought. This study failed to demonstrate any correlation between prior EBV or CMV infection and clinical course of Gaucher disease in patients homozygous for the N370S (1226G) mutation. The only positive finding was a higher level of anti-EBNA antibodies among patients with moderate/severe disease. In conclusion, other than a small subset of patients who showed a pattern comparable to immunosuppression, there was no association between severity of Gaucher disease and prior EBV or CMV infection.

Cytomegalovirus Infections↗

Prostaglandins in disorders of the intestinal tract: a review.

Prostaglandins (PGs) are natural oxygenated products of polyunsaturated fatty acids. They have multiple effects on the gastrointestinal tract. Their major physiological roles in the intestine are the promotion of solute and water secretion and the control of bowel motility. Prostaglandins have a role in the pathogenesis of diarrhea in a wide spectrum of gastrointestinal disorders. The effects and the potential contribution of PGs in various gastrointestinal disorders are discussed, and therapeutic modalities in these disorders are reviewed.

Humans↗

Hematopoietic progenitors in children with end-stage renal disease.

Bone marrow and circulating erythroid progenitors (BFU-E) in six anemic children with end-stage renal disease (ESRD) were 2.0 and 1.9 times as abundant, respectively, as in six age-matched normal controls and were significantly more responsive in vitro to low concentrations of recombinant human erythropoietin (rHuEpo) than those from the controls. After 4 weeks of rHuEpo therapy, both the number and the in vitro rHuEpo response of circulating BFU-E in the ESRD patients returned to normal control values. The numbers of bone marrow and circulating granulocyte-monocyte progenitors in the ESRD patients before and after rHuEpo therapy were comparable to those of normal controls. There was no inhibition of in vitro erythropoiesis by either the patients' serum or medium conditioned by their mononuclear cells. These results demonstrate a significant abundance and an increased rHuEpo sensitivity of BFU-E in anemic children with ESRD with no evidence of the presence of uremic inhibitors to erythropoiesis.

Adolescent↗